176 related articles for article (PubMed ID: 33289209)
1. p21-activated kinase 4 promotes the progression of esophageal squamous cell carcinoma by targeting LASP1.
Huang H; Xue Q; Du X; Cui J; Wang J; Cheng D; Li J; Zheng Y; Huang G; Zhang K; Liu K; Lu J; Zhao J; Chen X; Dong Z; Li X
Mol Carcinog; 2020 Dec; 60(1):38-50. PubMed ID: 33289209
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA circ_0006948 Promotes Esophageal Squamous Cell Carcinoma Progression by Regulating microRNA-3612/LASP1 Axis.
Tang R; Zhou Q; Xu Q; Lu L; Zhou Y
Dig Dis Sci; 2022 Jun; 67(6):2158-2172. PubMed ID: 34024023
[TBL] [Abstract][Full Text] [Related]
3. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF
J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725
[TBL] [Abstract][Full Text] [Related]
4. miR-143 inhibits migration and invasion through regulating LASP1 in human esophageal cancer.
Liu H; Zheng M; Zhao Y; Zhang S
Int J Clin Exp Pathol; 2019; 12(2):466-476. PubMed ID: 31933851
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of LASP1 is associated with proliferation, migration and invasion in esophageal squamous cell carcinoma.
He B; Yin B; Wang B; Chen C; Xia Z; Tang J; Yuan Y; Feng X; Yin N
Oncol Rep; 2013 Mar; 29(3):1115-23. PubMed ID: 23254782
[TBL] [Abstract][Full Text] [Related]
6. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y
J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115
[TBL] [Abstract][Full Text] [Related]
7. lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1.
Qu Y; Liu J
Onco Targets Ther; 2020; 13():8359-8370. PubMed ID: 32903907
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of long noncoding RNA breast cancer anti-estrogen resistance 4 inhibits cell proliferation, invasion, and migration in esophageal squamous cell carcinoma by regulating the microRNA-181c-5p/LIM and SH3 protein 1 axis.
Ke S; Fang M; Li R; Wang J; Lu J
Bioengineered; 2022 May; 13(5):12998-13010. PubMed ID: 35611706
[TBL] [Abstract][Full Text] [Related]
9. Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4.
Wei Y; Wu W; Jiang Y; Zhou H; Yu Y; Zhao L; Wu X; Lu X; Yuan Q; Wang Z; Dong Z; He L; Zhao J; Liu K
Br J Cancer; 2022 Apr; 126(7):1037-1046. PubMed ID: 34912075
[TBL] [Abstract][Full Text] [Related]
10. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
[TBL] [Abstract][Full Text] [Related]
11. Targeting p21-activated kinase 1 inhibits growth and metastasis via Raf1/MEK1/ERK signaling in esophageal squamous cell carcinoma cells.
Chen L; Bi S; Hou J; Zhao Z; Wang C; Xie S
Cell Commun Signal; 2019 Apr; 17(1):31. PubMed ID: 30971268
[TBL] [Abstract][Full Text] [Related]
12. The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K-AKT signaling pathway.
Zhang L; Lin S; Zhang Z; Yan C; Liu F
Clin Transl Oncol; 2023 Mar; 25(3):739-747. PubMed ID: 36593383
[TBL] [Abstract][Full Text] [Related]
13. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA LINC01296 promotes progression of oral squamous cell carcinoma through activating the MAPK/ERK signaling pathway via the miR-485-5p/PAK4 axis.
Zhang S; Wang X; Wang D
Arch Med Sci; 2022; 18(3):786-799. PubMed ID: 35591837
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
17. CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinoma.
Yu H; Yao J; Du M; Ye J; He X; Yin L
Oncol Lett; 2020 Jan; 19(1):542-548. PubMed ID: 31897169
[TBL] [Abstract][Full Text] [Related]
18. Protein Arginine Methyltransferase 5 Promotes Esophageal Squamous Cell Carcinoma Proliferation and Metastasis via LKB1/AMPK/mTOR Signaling Pathway.
Chen YR; Li HN; Zhang LJ; Zhang C; He JG
Front Bioeng Biotechnol; 2021; 9():645375. PubMed ID: 34124017
[No Abstract] [Full Text] [Related]
19. miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1.
Takeshita N; Mori M; Kano M; Hoshino I; Akutsu Y; Hanari N; Yoneyama Y; Ikeda N; Isozaki Y; Maruyama T; Akanuma N; Miyazawa Y; Matsubara H
Int J Oncol; 2012 Nov; 41(5):1653-61. PubMed ID: 22940702
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
